Exscientia receives open philanthropy grant to explore new therapeutic approach for pandemic influenza

Oxford, england--(business wire)--exscientia plc (nasdaq: exai) announced today that the company received a $2.3 million grant from open philanthropy, a philanthropic funder with several programs in global health and wellbeing. under this grant, exscientia aims to harness the activation of the host interferon response as a therapeutic approach for pandemic influenza. the grant comes in the context of the wider pandemic antiviral discovery (pad) initiative. out of the covid-19 pandemic experienc.
EXAI Ratings Summary
EXAI Quant Ranking